Intellipharmaceutics International Inc. reported earnings results for the first quarter ended February 28, 2023. For the first quarter, the company reported revenue was USD 0.326343 million compared to USD 0.083411 million a year ago. Net loss was USD 0.355738 million compared to USD 0.880972 million a year ago.

Basic loss per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago.